Skip to main content
Equibles
MRK logo

MRK · Merck & Co., Inc. · Investor Relations

Track MRK — free

Use MRK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MRK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$148.36 -1.16 (-0.78%) At close · Nov 2 Q2 2026 earnings call transcript
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$368.89B
Shares
2.47B
Volume · Nov 2 9.1M Avg daily vol (3M) 10.35M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2027-02-02 00:00 UTC Q4 2026 Earnings Call Earnings call
2027-04-29 00:00 UTC Q1 2027 Earnings Call Earnings call
2027-08-03 00:00 UTC Q2 2027 Earnings Call Earnings call
2027-10-28 00:00 UTC Q3 2027 Earnings Call Earnings call

Recent news

Date Headline
2026-10-29 Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2026 Financial Results; Highlights Multiple Milestones Advancing Broad, Diverse Pipeline
2026-10-22 Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA® (pembrolizumab) at ESMO 2026 Presidential Symposium
2026-10-13 Merck Showcases First-Time Pivotal Phase 3 Results From Oncology Pipeline and Continued Innovative Potential of Existing Portfolio at ESMO 2026
2026-10-10 Merck Presents One-Year Results from the Pivotal Phase 2b/3 BRUNELLO Study Evaluating Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, in Adults with Diabetic Macular Edema at AAO 2026
2026-10-01 Merck to Hold Third-Quarter 2026 Sales and Earnings Conference Call Oct. 29

Past events

Date Event Type
2026-10-29 Q3 2026 Earnings Call Earnings call
2026-10-26 Investor Event at ESMO 2026 Event
2026-09-14 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-09 2026 Wells Fargo Healthcare Conference Conference
2026-08-04 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-08-03 Investor Event at AIDS 2026, the 26th International AIDS Conference Event
2026-06-09 47th Annual Goldman Sachs Global Healthcare Conference Conference
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-06-01 Investor Event at ASCO 2026 Event
2026-05-26 2026 Annual Meeting of Shareholders Shareholder meeting
2026-04-30 Q1 2026 Earnings Call Earnings call
2026-03-25 Merck to Acquire Terns Pharmaceuticals Webcast
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-02-03 Q4 2025 Earnings Call Earnings call
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Conference

Source: https://www.merck.com/investor-relations/

Key facts CIK 310158 CUSIP 58933Y105 13F (30d) 1970 filings 1901 filers Visit website Investor relations